10x Genomics, Inc. vs Premier, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- 10x Genomics, Inc. is the larger company by market value: $9.4 B against $2.7 B for Premier, Inc., 3.5 times as much (market caps of Oct 26, 2026 for 10x Genomics, Inc. and Jan 5, 2024 for Premier, Inc.). Premier, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
- Premier, Inc. had more revenue: $1.4 B in the year to June 2022 against $643 M for 10x Genomics, Inc. in the year to December 2025.
- Premier, Inc. made a net profit of $265 M, while 10x Genomics, Inc. made a net loss of $44 M.
- Premier, Inc. keeps more of each dollar of sales: a net margin of 18.5% against -6.8% for 10x Genomics, Inc.
- Premier, Inc. employs more people: 2,600 against 1,243 at 10x Genomics, Inc. Each employee brings in about $517,152 of revenue at 10x Genomics, Inc. and $550,769 at Premier, Inc.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | 10x Genomics, Inc. TXG · #2,267 in the world | Premier, Inc. PINC |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Healthcare Information Services | Healthcare Information Services |
| Founded | 2012 | 1992 |
| Size | ||
| Market cap | $9.4 B | $2.7 B* |
| Revenue | $643 M | $1.4 B |
| Net income | $-44 M | $265 M▲ best |
| Employees | 1,243 | 2,600 |
| Valuation | ||
| Price to sales | 15.2× | — |
| Price to book | 11.8× | — |
| Free cash flow yield | 1.4% | — |
| Profitability | ||
| Gross margin | 69.0% | — |
| Operating margin | -9.5% | — |
| Net margin | -6.8% | — |
| Return on equity | -5.8% | — |
| Growth | ||
| Revenue growth | 5.3% | — |
| Revenue growth, 3 years a year | 7.6% | — |
| Cash | ||
| Free cash flow margin | 20.2% | — |
| Altman Z-score zone | safe | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Jan 2024 |
Questions and answers#
Which is bigger, 10x Genomics, Inc. or Premier, Inc.?
10x Genomics, Inc. is the larger company by market value: $9.4 B against $2.7 B for Premier, Inc., 3.5 times as much (market caps of Oct 26, 2026 for 10x Genomics, Inc. and Jan 5, 2024 for Premier, Inc.). Premier, Inc.'s value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Which makes more money, 10x Genomics, Inc. or Premier, Inc.?
Premier, Inc. had more revenue: $1.4 B in the year to June 2022 against $643 M for 10x Genomics, Inc. in the year to December 2025. Premier, Inc. made a net profit of $265 M, while 10x Genomics, Inc. made a net loss of $44 M.
Which is more profitable, 10x Genomics, Inc. or Premier, Inc.?
Premier, Inc. keeps more of each dollar of sales: a net margin of 18.5% against -6.8% for 10x Genomics, Inc.
Which has more employees, 10x Genomics, Inc. or Premier, Inc.?
Premier, Inc. employs more people: 2,600 against 1,243 at 10x Genomics, Inc. Each employee brings in about $517,152 of revenue at 10x Genomics, Inc. and $550,769 at Premier, Inc.